Friday, March 20, 2020 8:43:07 PM
Recent TNXP News
- Tonix Pharmaceuticals Announces Oral Presentation and Three Poster Presentations at the 2024 Military Health System Research Symposium (MHSRS) • GlobeNewswire Inc. • 08/21/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/20/2024 11:05:23 AM
- Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 CATALYST Study of TNX-1300 for the Treatment of Cocaine Intoxication • GlobeNewswire Inc. • 08/20/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 10:05:58 AM
- Tonix Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Highlights • GlobeNewswire Inc. • 08/19/2024 10:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/16/2024 09:18:38 PM
- Tonix Pharmaceuticals Provides Update on the Development of Its Single Dose Live Attenuated Virus Vaccine Candidate for Mpox, TNX-801, as WHO Declares Mpox Outbreak a Global Health Emergency • GlobeNewswire Inc. • 08/16/2024 11:00:00 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2024 10:03:25 AM
- Tonix Pharmaceuticals to Present at the Summer 2024 Virtual Investor Summit • GlobeNewswire Inc. • 08/13/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 12:18:07 PM
- Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia, the Prototypic Nociplastic Pain Syndrome, at the IASP 2024 World Congress on Pain • GlobeNewswire Inc. • 08/12/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 09:22:42 PM
- Tonix Pharmaceuticals Announces Publication in Microorganisms of Technology that Expands Company’s Capabilities in Generating Potential Therapeutic Fully Human Antibodies Against SARS-CoV-2 and Other Pathogens • GlobeNewswire Inc. • 08/06/2024 12:00:00 PM
- Tonix Pharmaceuticals Announces Potential Positive Impact of the U.S. National Academies (NASEM) New Definition of Long COVID on the Size of the Fibromyalgia Market for Tonmya™ • GlobeNewswire Inc. • 07/31/2024 12:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/30/2024 09:17:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 09:08:39 PM
- Tonix Pharmaceuticals Announces Poster Presentation at the IASP 2024 World Congress on Pain • GlobeNewswire Inc. • 07/30/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 12:06:45 PM
- Tonix Pharmaceuticals Granted Fast Track Designation by FDA for Tonmya™ for Fibromyalgia • GlobeNewswire Inc. • 07/25/2024 12:00:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/24/2024 09:14:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 01:12:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 08:48:25 PM
- Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering • GlobeNewswire Inc. • 07/10/2024 08:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/09/2024 08:33:32 PM
- Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering • GlobeNewswire Inc. • 07/09/2024 01:15:00 PM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM